Toke Signals Bud Pick of the Week
Toke Signals Stories of the Week
The research, published in the journal JAMA Psychiatry, challenges some previous studies which claimed an association between marijuana use and both depression and anxiety, reports Christopher Ingraham at The Washington Post.
Scientists examined the records of nearly 35,000 American adults who participated in the National Epidemiologic Survey on Alcohol and Related Conditions. They looked at the prevalence of cannabis use among study participants in 2001 and 2002, then checked on their rates of mental health problems three years later, in 2004 and 2005.
After controlling for confounding factors such as socioeconomic differences, family history, environment, and past and present psychiatric disorders, researchers found that “cannabis use was not associated with increased risk for developing mood or anxiety disorders.”
U.S. Department of Justice Inspector General Michael E. Horowitz on Thursday released a new report on the federal Drug Enforcement Administration which exposes the DEA’s failure to comply with rules for tracking, recording, and processing seized drug evidence.
“Unknown quantities of drugs are being left vulnerable to theft because, among other issues, evidence is not being processed in a timely manner, or in some cases, at all,” media relations associate Mikayla Hellwich of Law Enforcement Against Prohibition (LEAP) told Hemp News Friday afternoon.
Nearly 70 percent of drug seizures examined by the Inspector General were placed in “temporary storage” for more than the maximum allowed three days, according to the IG’s office, reports Eric Katz at Government Executive. During that period, the drug “exhibits” aren’t entered into the tracking system.
Additionally, according to the IG’s report, the DEA isn’t properly tracking the third-party shipping vendors when they are required to send seized drugs for laboratory testing.
When Washington state’s marijuana legalization law, I-502, passed, it didn’t take long until folks figured out it is the most badly written “legalization” law yet passed. It’s so badly written, in fact, that under this purportedly “progressive” legislation, it’s a felony to pass a joint to your significant other.
Since the people of Washington apparently didn’t read the damn thing before they passed I-502, seemingly not making it past “legalization” and thinking “how bad could THAT be?”, it now falls upon the hapless Washington Legislature to fix the mess — and that’s pretty damn scary to anyone who knows just how clueless is that body of lawmakers when it comes to cannabis.
But they get points for trying, at least when it comes to the sharing issue. House Bill 2494, “An act relating to penalties for marijuana offenses,” on Monday passed the Washington House on a 73 to 24 vote, and has been referred to committee in the Senate, reports Jake Ellison at the Seattle PI.
The bill would finally allow adults 21 and older to share up to half an ounce of cannabis flowers, eight ounces of infused edibles, and 36 ounces of cannabis-infused drinks, without being guilty of a felony as has been the case since this weird-ass brand of corporate “legalization” kicked in back in 2012.
The two companies authorized to grow cannabis in the South American nation have started production of the crop, reports Fox News Latino.
ICCorp and Simbiosys “are already working in the fields of the Cannabis Regulation and Control Institutte, or IRCCA, to produce and distribute marijuana, reports Ecos.la.
Technicians and experts spent a week preparing the fields, located in the southwestern province of San Jose, to grow cannabis.
The Utah Senate could soon urge Congress to change the classification of marijuana, currently considered Schedule I under the Uniform Controlled Substances Act, to Schedule II, which could open the door for more medicinal cannabis research.
Senate Concurrent Resolution 11, sponsored by Sen. Brian Shiozawa (R-Salt Lake), would require the approval of the full Utah Legislature and Governor Gary Hebert, reports Jeremy Harris at KUTV.
Marijuana’s current classification as Schedule I means that the U.S. federal government considers cannabis to be as dangerous as heroin and has “no currently accepted medical use and a high potential for abuse.” Both cocaine and methamphetamine, incredibly, are considered Schedule II, thus less dangerous than marijuana, by the feds.
Shiozawa’s resolution would urge Congress to reclassify marijuana to Schedule II. The downside to classifying cannabis as Schedule II, rather than de-scheduling it altogether, is that a Schedule II classification would effectively put marijuana under the tight control of Big Pharma.
While marijuana product recalls have seemingly become commonplace in Colorado, Washington state had seemed remarkably free of such problems — until now. Washington-based Evergreen Herbal on Friday issued the state’s first voluntary cannabis product recall due to pesticide concerns.
The recall is an indirect result of two producers, New Leaf Enterprises and BMF Washington, recently being investigated by the Washington State Liquor and Cannabis Board (WSLCB) for using prohibited pesticides.
While the LCB did find prohibited pesticides on cannabis products from both companies and made them pay fines of $2,500 and suspend operations for 10 days, interestingly, BMF — despite using no fewer than 12 prohibited pesticides — was allowed to continue selling tainted flowers with a “warning label” after paying the fine. (All concentrates were destroyed upon orders of the LCB; the process of making concentrates also means higher levels of poison, as well as THC.)
Evergreen Herbal, clearly not wanting to end up like New Leaf and BMF, announced its voluntary product recall via press release on Friday, reports Graham Abbott at Ganjapreneur. The three products being recalled are the high-CBD edibles Hibiscus Quencher, Strawberry Quencher, and CBD Dark Chocolate 420 Bar; all three were, at one point, produced using Dama CBD oil, according to Evergreen.
Protesters gathered at the State House in the Capitol last week, asking lawmakers to allow safe access to medical marijuana.
“You can’t spell healthcare without THC!” said protester Faye Medlock of the Medical Cannabis Advocates of Alabama, reports Caitlin Cline at Alabama News. “So many people that this could help, and the government is hindering,” said Medlock, who added cannabis helps her fibromyalgia and irritable bowel syndrome.
Marijuana is illegal for any purpose in Alabama, except for the narrow exception of Carly’s Law, under which only the UAB Hospital and the Children’s Hospital of Alabama are allowed to administer CBD oil (cannabidiol is a nonpsychoactive component of marijuana) to research patients.
Getting the entire plant legalized for medicinal use is the goal of the Medical Cannabis Advocates. It’s something that protester Regina King Vinzant said is worth fighting for, for her health.